| Regency Southerncare-metro Atlanta 1051 Culpepper Drive Sw, Conyers, GA, 30094 | |
| (678) 413-1360 |
News Archive
Results of a small study from Japan in this week's issue of THE LANCET suggest that the emergence of influenza viruses which are resistant to a widely used influenza drug may be more common than previously thought.
Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.
› Verified 6 days ago
| Name | Regency Southerncare-metro Atlanta |
|---|---|
| Location | 1051 Culpepper Drive Sw, Conyers, Georgia |
| Hospice ID | 111668 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Other |
| Profit Type | FOR PROFIT |
| SSA county code | 841 |
News Archive
Results of a small study from Japan in this week's issue of THE LANCET suggest that the emergence of influenza viruses which are resistant to a widely used influenza drug may be more common than previously thought.
Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.
› Verified 6 days ago
| NPI Number | 1104031863 |
| Organization Name | At Home Healthcare And Hospice Llc |
| Address | 1051 Culpepper Dr Sw # 100 Conyers, Georgia, 30094 |
| Phone Number | (678)413-1360 |
News Archive
Results of a small study from Japan in this week's issue of THE LANCET suggest that the emergence of influenza viruses which are resistant to a widely used influenza drug may be more common than previously thought.
Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.
› Verified 6 days ago
| NPI Number | 1619093788 |
| Organization Name | Serenity Health Care And Hospice |
| Address | 1380 Milstead Ave Ne Conyers, Georgia, 30012 |
| Phone Number | (678)413-1360 |
News Archive
Results of a small study from Japan in this week's issue of THE LANCET suggest that the emergence of influenza viruses which are resistant to a widely used influenza drug may be more common than previously thought.
Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.
› Verified 6 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 93.3 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 67.7 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 70.2 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 50.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 97.3 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 96.8 | 93.3 |
News Archive
Results of a small study from Japan in this week's issue of THE LANCET suggest that the emergence of influenza viruses which are resistant to a widely used influenza drug may be more common than previously thought.
Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.
› Verified 6 days ago
| Home Health Aides | 3.75 |
| Counselors | 1 |
| Licensed Practical or Vocational Nurses | 5 |
| Medical Social Workers | 1 |
| Physicians | 0.25 |
| Registered Nurses | 3.5 |
| Other Personnel | 3 |
| Total Employees | 17.5 |
|---|
News Archive
Results of a small study from Japan in this week's issue of THE LANCET suggest that the emergence of influenza viruses which are resistant to a widely used influenza drug may be more common than previously thought.
Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.
› Verified 6 days ago
| Others | 14 |
| Total Volunteers | 14 |
|---|
News Archive
Results of a small study from Japan in this week's issue of THE LANCET suggest that the emergence of influenza viruses which are resistant to a widely used influenza drug may be more common than previously thought.
Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Amid growing concerns over the increasing number of people fleeing from escalating violence in Cote d'Ivoire, the U.N. World Food Program on Friday announced plans to boost food aid to tens of thousands of displaced people and the families hosting them in other countries, AlertNet reports.
Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.
› Verified 6 days ago
| Regency Southerncare-metro Atlanta Location: 1051 Culpepper Drive Sw, Conyers, Georgia, 30094 Phone: (678) 413-1360 |
| Magnolia Hospice Location: 923 Center Street, Conyers, Georgia, 30012 Phone: (678) 413-1360 |
| Hospice Nurses Of Georgia, Llc Location: 2385 Wall Street Suite 119, Conyers, Georgia, 30013 Phone: (678) 413-1360 |
| Circle Of Angels Hospice Inc Location: 2817 Highway 212 Sw, Conyers, Georgia, 30094 Phone: (678) 413-1360 |